The temperature-sensitive mutant tsp53 val135 accumulates in the cytoplasm of cells kept at the non-permissive temperature (398C), but is rapidly transported into the cell nucleus at the permissive temperature (308C). tsp53 thus may serve as a model for analysing cellular parameters in¯uencing the subcellular location of p53. Here we provide evidence that retention of tsp53 in the cytoplasm at the non-permissive temperature is due to cytoskeletal anchorage of the p53 protein. Two sublines of C6 rat glioma cells diering in their expression of the intermediate ®lament protein vimentin (vimentin expressing or vimentin negative cells) were stably transfected with a vector encoding tsp53. Whereas cells of vimentin expressing C6 subclones retained tsp53 in the cytoplasm at the non-permissive temperature, cells of vimentin negative subclones exclusively harbored the tsp53 within their nuclei. Intermediate ®lament de®cient cells that had been reconstituted with a full length vimentin protein again showed a cytoplasmic localization of tsp53, whereas in cells expressing a C-terminally truncated (tail-less) vimentin tsp53 localized to the nucleus. We conclude that cytoplasmic sequestration of tsp53 requires an intact intermediate ®lament system.
Introduction
The tumor suppressor p53 is a multifunctional protein, exerting a variety of functions in cell cycle control, DNA repair, DNA recombination, initiation of apoptosis, and control of dierentiation (Gottlieb and Oren, 1996; Ko and Prives, 1996) , rendering it the currently most prominent`gate-keeper of cell growth and dierentiation' (Levine, 1997) . In line with this central role of p53 is the observation that inactivation of wild-type speci®c functions of p53 by mutations in the p53 gene is a very frequent event in human tumors (Hollstein et al., 1991; Hainhaut et al., 1997) . Most of these mutations are missense point mutations, leading to the expression of a mutant p53 carrying a single amino acid substitution (Cho et al., 1994; Hollstein et al., 1996; Medcalf et al., 1992) . The unusual mutational spectrum (490% missense point mutations, localized within the p53 core domain) led to the hypothesis that these mutations do not simply inactivate the tumor suppressor functions of wild-type (wt) p53, but provide a`gain of function' for the mutant (mt) p53 (Deppert, 1996; Dittmer et al., 1993) . This hypothesis is supported by a variety of biological and biochemical observations, which strongly suggest that mt p53 exerts properties of a dominant oncogene.
The multitude of functions ascribed to either wt or mt p53 requires that the functional properties of these proteins are tightly and coordinatedly regulated. In addition to various posttranslational modi®cations and interactions with viral and cellular proteins (Deppert, 1994a, b) , the subcellular location of p53 seems to be an important determinant of its function (Shaulsky et al., 1991) . The p53 molecule is endowed with three nuclear translocation signals (NLS) (Shaulsky et al., 1990b) , but, in addition, also contains a nuclear export signal (Middeler et al., 1997) , suggesting that p53 is able to shuttle between the cytoplasmic and the nuclear compartment, depending on functional requirements. Indeed, there is ample evidence for a functiondependent localization of p53 to either cellular compartment. When resting cells resume cycling, wt p53 remains in the cytoplasm during G1 phase, but is translocated into the nucleus at the onset of S-phase (Shaulsky et al., 1990a) , in accordance with a role of wt p53 in translational control of its own mRNA in G1 (Mosner et al., 1995) . During dierentiation of neurons and oligodendrocytes explanted from embryonic rat brain, wt p53 is translocated into the nucleus and is relocated to the cytoplasm in dierentiated cells (Eizenberg et al., 1996) . Similarly, wt p53 is overexpressed and located in the cytoplasm in normal lactating breast tissue suggesting a role for nuclear exclusion of p53 in the developing mammary gland (Moll et al., 1992) .
Variations in subcellular localization were also noticed in tumor cells expressing wt p53. In certain mammary carcinomas and in undierentiated neuroblastomas wt p53 accumulates within the cytoplasm, whereas it localizes to the nucleus in dierentiated neuroblastomas (Moll et al., 1992 (Moll et al., , 1995 .
Like the subcellular localization of wt p53, also that of mt p53 is subject to considerable variation, ranging from exclusively cytoplasmic to exclusively nuclear in tumors and in transformed cells (Porter et al., 1992; Rotter et al., 1983; Takahashi and Suzuki, 1994) . Importantly, the subcellular localization of mt p53 is not a function of speci®c mutations in the p53 gene, as in human glioblastomas a speci®c mt p53 protein (codon 273; Arg?Cys) localized to the nuclei in some tumors, but to the cytoplasm in others, indicating that the subcellular localization of mt p53 is not determined by the mutation itself, but may be dependent on environmental conditions in the cell (Ali et al., 1994) , and/or its functional status. The latter has been observed with mt p53 in MethA tumor cells, which in cycling cells is predominantly nuclear, but becomes transferred to the cytoplasm when the cells growth arrest at the restriction point in G1 (Steinmeyer and Deppert, 1988) . All these data argue that the subcellular localization of p53 is subject to certain regulatory mechanisms within the cell, some of which might be connected with the status of dierentiation. However, the factors regulating the presence both of mt and of wt p53 in dierent subcellular locations are still largely unknown.
The temperature-sensitive mutant p53 val135 in the past has proven a useful system to analyse cellular parameters in¯uencing the subcellular location of both mt and wt p53. At the non-permissive temperature (4378C), tsp53 is present in its mutant form and localizes predominantly to the cytoplasm. Upon shift to the permissive growth temperature (30 ± 328C), the tsp53 adopts its wild-type form, becomes translocated to the cell nucleus and exerts wt p53 functions (Martinez et al., 1991; Michalovitz et al., 1990) , i.e. induction of growth arrest or apoptosis, depending on cell type. However, there is neither a strict dependence for a cytoplasmic location of tsp53 when present in its mutant form, nor for a nuclear location when present in its wild-type form, indicating that cellular and/or functional parameters rather than its conformational state determine the subcellular location of tsp53. Thus the cytoplasmic localization of tsp53 at the nonpermissive temperature can be converted to a nuclear one by treating the cells with translational inhibitors, indicating that continuous protein synthesis is necessary to retain this mutant protein within the cytoplasm, possibly via short lived cytoplasmic anchor proteins (Gannon and Lane, 1991) . Conversely, tsp53 does not localize to the nucleus in PC12 cells even at the permissive temperature, and is redistributed to the cytoplasm in clone 6 cells, when the cells are kept at the permissive temperature for a prolonged time. In both instances, cytoplasmic localization of tsp53 at the permissive temperature correlated with loss of wt p53 function (Knippschild et al., 1996) .
Whereas the nuclear location of p53 is understood as a consequence of the speci®c transport of p53 to its major functional location, very little is known about the mechanism retaining p53 in the cytoplasm. Cell fractionation studies showed that cytoplasmic tsp53 resists extraction of cells with non-ionic detergents when applying conditions normally used to identify the association of proteins with the cytoskeleton. This not only was found for cytoplasmic tsp53 both in its wildtype as well as in its mutant form, but could be extended to cytoplasmic wt p53 in other systems (Gannon and Lane, 1991; Knippschild et al., 1996; Moll et al., 1996; Rotter et al., 1983; Zerrahn et al., 1992) , pointing to a general role of cytoskeletal structures for the cytoplasmic localization of p53.
Using tsp53 val135 as an experimental system we asked in this study, whether any and which of the major cytoskeletal ®lament systems, namely actin ®laments, microtubules, or intermediate ®laments would serve as a backbone for cytoplasmic anchorage of p53 molecules. The question of an involvement of actin or tubulin in the subcellular localization of cytoplasmic proteins can easily be addressed by the use of inhibitors which speci®cally aect the structural arrangement of these ®lament systems. In contrast, an involvement of intermediate ®laments is more dicult to assay due to the stability of this system under physiological conditions, and due to the absence of speci®c inhibitors. Therefore we used a cell system which is based on C6 rat glioma cells. From these cells subclones were isolated (RoÈ ser et al., 1991) that either express or do not express vimentin, the most common intermediate ®lament protein expressed in cultured cells (Traub and Vorgias, 1983) . Such cells thus either contain or are de®cient of a cytoplasmic intermediate ®lament system. Ectopic expression of tsp53 in these cells demonstrated that tsp53 was strictly nuclear in cells of vimentin-negative subclones, whereas cytoplasmic sequestration of tsp53 was dependent on an intact intermediate ®lament system. The system of vimentinexpressing and vimentin-negative C6 subclones should provide a valuable experimental system for the identi®cation of mechanisms regulating the subcellular localization of p53.
Results

tsp53 is bound to the cytoskeleton in IF (vimentin) positive cells
Cytoskeletal anchorage of p53 was ®rst assayed in vimentin-expressing C6D8 cells stably transfected with tsp53. C6D8 cells contain intermediate ®laments (vimentin) in addition to microtubules and actin ®laments (RoÈ ser et al., 1991) . By immunofluorescence, Western-and Northern-blotting, the parental cells do not express detectable levels of endogenous p53, which could interfere with or mask the function of an ectopic p53 (data not shown). By immunofluorescence and by Western-blotting the p53 antibodies used did not cross-react with any other structural component in these cells.
Eleven out of 20 subclones isolated after transfection with vector pLTRcG9 expressed tsp53, eight of them showing a very strong cytoplasmic immuno¯uorescence staining of tsp53 at 398C (see Figure 1B for a representative example). In addition to the consistently strong cytoplasmic staining for p53 in these cells, also some nuclear staining could be observed, varying considerably in intensity from complete absence to dot-like inclusions. Nuclear inclusions were present independently of the way the cells were treated prior to ®xation and therefore did not re¯ect an artefact due to improper handling of the probes. A comparative analysis of the arrangement of actin, tubulin, and vimentin ®lament systems in tsp53 transfected versus non-transfected cells revealed no dierences, indicating that ectopic expression of tsp53 did not alter the normal arrangement of these ®lament systems. To determine binding of tsp53 to the cytoskeleton the cells were lysed with a non-ionic detergent, applying conditions which were shown to produce properly preserved cytoskeletons without remnants of membrane (Bohn et al., 1993; Nebe et al., 1997; Okabe and Hirokawa, 1988) . The strong cytoplasmic¯uorescence signal of tsp53 in extracted cells ( Figure 1D ) suggested that the bulk of this protein was not lost during cell lysis but was retained on the cytoskeleton. Correspondingly, the amount of tsp53 in the supernatant lysis buer (fraction S) was low in comparison to that in the detergent insoluble cytoskeletal fraction (fraction I) as determined by Western immunoblotting ( Figure 1D : insert).
p53 relocalizes with vimentin but not with actin or tubulin in drug treated cells
To evaluate which of the major ®lament systems might be involved in cytoplasmic localization of tsp53 we ®rst followed the subcellular distribution of the p53 protein in cells treated with ®lament speci®c drugs. Cytochalasin B was used to determine if the subcellular localization of cytoplasmic tsp53 could be aected by disruption of the actin ®lament network. Cytochalasin induced fragmentation of actin ®laments and redistribution of actin into patches concomitant with changes in cell shape (compare FITC-labeling in Figure 2A and B). However, p53 (TRITC-labeling in Figure 2C ) did not comigrate with actin into these patches (compare Figure 2B and C) and the majority of the tsp53 still remained bound to the cytoskeleton after extraction of these cells with a non-ionic detergent ( Figure 2C ).
To determine an involvement of microtubules in subcellular localization of tsp53, we incubated the cells with vinblastin. This microtubule speci®c drug rearranged tubulin into paracrystalline aggregates (compare FITC-labeling in Figure 3A and B) and cytoplasmic p53 (TRITC-labeling in Figure 3B ) now localized close to the nucleus. The vimentin network collapsed and was arranged around the nucleus in a whirl like manner (FITC-labeling in Figure 3C ). tsp53 (TRITC-labeling in Figure 3D ) remained bound to the cytoskeleton after cell lysis also under these conditions, and colocalized with the rearranged vimentin. These data suggested that the distribution of tsp53 in the cytoplasm of C6D8 cells was neither determined by microtubules nor by the actin ®lament network, but seemed to follow the distribution of the intermediate ®lament protein vimentin.
tsp53 complexes are attached to cytoskeletal ®laments at the EM level Our data obtained so far point to an association of tsp53 with the cytoskeleton involving the vimentin network. We next analysed the interaction of p53 with the cytoskeleton by immunoelectron microscopy, as this approach allows a more precise location of p53 to cytoskeletal elements than immuno¯uorescence microscopy. Cells were grown on glass coverslips, and lysed with a non-ionic detergent as detailed in Materials and methods. p53 was identi®ed by immunogold labeling with the monoclonal p53 antibody PAb248. Cytoskeletons of tsp53 transfected cells exhibited a strong labeling with the p53 antibody ( Figure 4A ). In controls only a few gold particles were scattered throughout the network without any preferential association with ®laments ( Figure 4B ). The immunogold particles identifying p53 were not evenly distributed throughout the network, but were concentrated at complexes attached to individual ®laments (Figure 4C and D) . In accordance with previous observations using this cell line (Bohn et al., 1993; Foisner et al., 1995) , these ®laments were of intermediate size and thus represented vimentin ®laments. This could also be veri®ed by immunogold double-labeling showing that Cytoplasmic retention of tsp53 O Klotzsche et al p53 containing complexes identi®ed by 5 nm gold particles were associated with ®laments that were labeled with vimentin antibodies and 10 nm immunogold particles ( Figure 4D ).
IF-negative cells accumulate tsp53 within the nucleus
If vimentin indeed would be of functional importance for the subcellular localization of tsp53, then cells which are devoid of cytoplasmic IF proteins should show an altered subcellular localization of tsp53. When the vimentin-de®cient C6D10 cells were stably transfected with tsp53, eight out of 20 subclones randomly selected showed expression of tsp53. Transfection of C6D10 cells did not lead to reexpression of vimentin in these subclones as determined by immuno¯uorescence labeling with a polyclonal vimentin antibody ( Figure 5A ). All cells exhibited a strong nuclear staining of tsp53 in immuno¯uorescence already at the non-permissive temperature ( Figure 5B ), whereas no, or only very little cytoplasmic staining was observed. Very low amounts of tsp53 were present within the detergent soluble fraction as assayed by Western immunoblotting, providing evidence that the nuclear tsp53 in these cells was tightly bound (Figure 5B : insert).
Vinblastin treated
Tubulin Tubulin/p53 untreated Vinblastin treated Cells with a restored vimentin scaold accumulate tsp53 within the cytoplasm (Bohn et al., 1992) . This again led to a cytoplasmic accumulation of tsp53 at the non-permissive temperature of 398C, whereas only low amounts of p53 were found within the nucleus ( Figure  5D ). Again, the cytoplasmic tsp53 was retained in the cytoskeletal fraction after lysis with non-ionic detergents. Thus complementation of cells of the IFde®cient C9 subclone with vimentin enabled binding of tsp53 to the cytoskeleton.
Cells expressing a tail-less vimentin protein accumulate tsp53 within the nucleus
To further demonstrate the speci®city of the interaction of p53 with a vimentin cytoskeleton we analysed the subcellular localization of tsp53 in cells expressing a truncated vimentin protein, which is still able to form a ®lament network. Whereas the aminoterminal domain, the head domain, is indispensable for assembly of vimentin proteins into ®laments, truncation of the carboxyterminal domain, the tail domain, does not prevent this assembly process, but seems to aect the arrangement of these ®laments into a proper network within the cell (Eckelt et al., 1992; Herrmann et al., 1992; McCormick et al., 1993; Traub and Vorgias, 1983) . IF-de®cient C6D10 cells were transfected with an expression vector coding for a vimentin protein lacking the carboxyterminal tail domain due to the presence of a stop codon at the end of the rod domain coding sequence. This tail-less vimentin protein also contained the VIM3B4 epitope. Immuno¯uorescence staining of stably transfected cells with VIM3B4 exhibited an irregular vimentin network, which was restricted to the cytoplasm ( Figure 5E ). In Western immunoblots a 50 kD vimentin protein could be detected with the VIM3B4 antibody ( Figure 6 , lane 8), whereas no reaction was obtained with the V9 antibody ( Figure 6 , lane 4), again verifying the absence of endogeneous vimentin. When these cells were transfected with the tsp53 expression vector, 11 out of 20 subclones isolated showed expression of tsp53. All of them exhibited a strong nuclear, but no signi®cant cytoplasmic staining of tsp53 already at the non-permissive temperature ( Figure 5F ), suggesting that the tail domain of vimentin is essential for the cytoplasmic sequestration and cytoskeletal anchorage of tsp53.
Disassembly of a preexisting vimentin scaold redistributes cytoplasmic tsp53
We next wanted to know whether the breakdown of a preexisting vimentin ®lament network in cells in which tsp53 is anchored to the cytoskeleton would directly aect the subcellular localization of tsp53. The assembly of vimentin protein into ®laments is eciently prevented by mutations in the aminoterminal head domain of vimentin Traub and Vorgias, 1983) . Such mutant vimentin thus can be used to disturb an existing vimentin system by ectopic expression. Therefore, we transiently transfected tsp53 expressing, vimentin-positive C6D8 cells with a vimentin expression vector encoding a mutated vimentin protein lacking aa 43 ± 102 of the aminoterminal head domain. After transfection, the cells were ®xed with acetone and double-labeled with antibodies to vimentin and p53. The transfected cells showed dramatic rearrangements of vimentin into cytoplasmic aggregates ( Figure 7A and C). tsp53 was redistributed within these cells and largely colocalized with these vimentin aggregates ( Figure 7B ). No enhanced nuclear accumulation of tsp53 was detectable in these cells. In contrast to the drastic changes in subcellular distribution of tsp53, the distribution of actin was not aected by this vimentin rearrangement ( Figure 7C and D) , verifying that the redistribution of p53 induced by these conditions not merely re¯ected an unspeci®c rearrangement of cytoplasmic components.
Discussion
Using the temperature-sensitive mutant tsp53 we show that in C6 rat glioma cells at the non-permissive temperature the subcellular localization of tsp53 is dependent on whether these cells express, or do not express an intact intermediate ®lament (vimentin) protein scaold. In vimentin-positive C6 cells, tsp53
Val-135 largely accumulated within the cytoplasm in accordance with its behaviour in other cell types (Gannon and Lane, 1991; Knippschild et al., 1996; Martinez et al., 1991; Michalovitz et al., 1990) . Vimentin-negative C6 cells, in contrast, exclusively harbored the tsp53 protein within the nucleus, whereas the same cells when reconstituted with vimentin again showed a cytoplasmic accumulation of tsp53. Thus, depending on the intracellular environment of the cell, a given mutant p53 protein will behave dierently with respect to its subcellular localization. An association of cytoplasmic p53 with components of the cytoskeleton has already been suggested previously (Knippschild et al., 1996; Rotter et al., 1983 ). Here we demonstrate that this interaction is dependent on an intact intermediate ®lament (vimentin) system. Vimentin ®laments are arranged in close interaction with other ®lament systems, and serve as a backbone for the spatial organization of various cellular organelles (Albers and Fuchs, 1992; Janmey et al., 1991; Lazarides, 1980) . In C6 cells the vimentin ®laments were shown to be physically linked to microtubules and to the actin ®lament system via thin connecting ®laments that are composed of plectin (Foisner et al., 1995) . Therefore, one could argue that the observed vimentin-dependent anchorage of tsp53 to the cytoskeleton could re¯ect a stabilizing eect of vimentin on other cytoskeletal ®lament systems to which tsp53 would be bound. However, neither destruction of the actin ®lament system by cytochalasin, nor the breakdown of the microtubule system by vinblastin displaced tsp53 from the cytoskeleton, nor did these treatments induce translocation of tsp53 into the nucleus. After treatment with both agents the majority of tsp53 was still retained on the cytoskeleton and followed the arrangement of vimentin. In contrast, disrupting the vimentin ®lament network in vivo by coexpression of a trans-dominant interfering aminoterminally truncated vimentin protein redistributed tsp53. These data render it extremely unlikely that tsp53 retained on extracted cells is simply trapped
Vimentin Actin Vimentin p53 unspeci®cally by the cytoskeleton, but rather point to a speci®c association of the tsp53 with the vimentin scaold. The speci®city of this interaction is further substantiated by our observation that reconstitution of a vimentin system using a tail-less vimentin failed to retain tsp53 in the cytoplasm. Tail-less vimentin in these cells formed an irregular network which resisted extraction with nonionic detergents, indicating that the truncated vimentin was not soluble, but still was able to form stable structures within the cell. These data argue that either a properly organized vimentin ®lament network or the vimentin tail domain itself is necessary to retain tsp53 on the cytoskeleton. While the function of the head domain of vimentin has well been described, that of the tail domain is still not completely understood (Ciesielski-Treska et al., 1991; Inagaki et al., 1990; Ogawara et al., 1995; Traub and Vorgias, 1983) . Probably, the tail controls the lateral association of IF-protein tetramers and thereby stabilizes the ®lament structure, which may be essential to establish a proper ®lament network (Heins and Aebi, 1994) . In addition the tail domain is exposed at the ®lament surface (Troncoso et al., 1990) , and thus is easily accessible to interaction with proteins. The tail domain therefore may be required for an interaction with cellular components (Bader et al., 1991; Eckelt et al., 1992) , a suggestion which would correspond to our observations shown here. Despite the documented importance of the vimentin scaold for the cytoplasmic anchorage of tsp53, there is at least indirect evidence that this anchorage is not mediated via a direct association of the p53 protein with vimentin molecules. Firstly, our immunoelectron microscopic images clearly showed that tsp53 was not distributed along vimentin ®laments, but rather was found in association with so far unidenti®ed protein complexes attached to these ®laments. Also the ®nding that the association of tsp53 with the intermediate ®lament scaold is sensitive to a short treatment of the cells with inhibitors of protein biosynthesis argues against a direct interaction of tsp53 with vimentin, as the vimentin ®lament system as such is not noticeably disturbed under such conditions (unpublished observation). We therefore favour the hypothesis that tsp53 is not directly anchored to the ®lament network, but is indirectly bound via a linker protein which has an anity for vimentin (intermediate) ®laments and is subject to regulatory mechanisms. This would also be compatible with the previous suggestion that tsp53 is retained in the cytoplasm by a short lived anchor protein(s) (Gannon and Lane, 1991; Knippschild et al., 1996) . Nothing, so far is known about the postulated bridging or anchor protein(s) mediating the association of p53 with the vimentin scaold. The constitutively expressed heat shock protein hsc70 which preferentially binds to tsp53 in its mutant conformation (Gannon and Lane, 1991; Hinds et al., 1987; Pinhasi-Kimhi et al., 1986) in theory could represent such an anchor protein. Chaperones themselves have an anity for intermediate ®laments (Cheng and Lai, 1994; Liao et al., 1995) and therefore could link p53 to the cytoskeleton. However, tsp53 can be retained in the cytoplasm of IF-positive cells even when present in its properly folded wild-type conformation, to which hsc70 does not bind (Knippschild et al., 1996) . In addition, hsc70 stayed in complex with tsp53, when the cytoplasmic localization of tsp53 was lost in the presence of cycloheximide (Gannon and Lane, 1991) , arguing against a role of hsc70 in cytoplasmic sequestration.
It is tempting to speculate that the mechanisms, which are responsible for the vimentin-dependent subcellular localization of tsp53 in C6 rat glioma cells may be of general relevance for the cytoplasmic sequestration of either mutant or wild type p53 in tumor cells. This speculation is supported by the observation that in clone 6 cells tsp53 in its wild-type form was excluded eciently from the nucleus upon prolonged cultivation of the cells at the permissive temperature (Knippschild et al., 1996) . Again, this cytoplasmic p53 resisted extraction with non-ionic detergents. However, so far no detailed studies have been conducted on a possible correlation between the subcellular localization of p53 and the IF-expression patterns in tumors or in cultured cells derived thereof.
The experimental system established here should oer a reasonable approach to obtain more insight into the mechanisms regulating the subcellular localization of p53, expecially its speci®c retention in the cytoplasm, and should allow the identi®cation of additional proteins involved in this process.
Materials and methods
Cell culture
C6 rat glioma cells were grown in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 10% fetal calf serum (FCS). Media used for selection of transfected cells either contained Geneticin (400 mg/ml) or both Geneticin (400 mg/ml) and Hygromycin B (100 mg/ml).
Vimentin and tsp53 expression vectors
A full length mouse vimentin cDNA (Hennekes et al., 1990) was subcloned into the eukaryotic expression vector pSG5 (Stratagene, La Jolla) which drives expression of the inserted cDNA by the SV40 early promoter. At position 353 of this vimentin protein valine was substituted for leucine by in vitro mutagenesis (Bohn et al., 1992) to facilitate speci®c recognition of this protein by the VIM3B4 antibody. This plasmid was designated pMBVim2. The vimentin expression vector pVimEco is identical to pMBVim2 but contains a stop codon immediately after the sequence coding for helix 2B. This vimentin protein thus lacked the complete tail domain. The expression vector D61 codes for a vimentin protein lacking AS 50 ± 104 of the head domain. Expression of the murine tsp53
Val135 was based on the eukaryotic expression vector pLTRcG9 (Eliyahu et al., 1985) .
Stable transfection
Transfection of C6 subclones was carried out by electroporation. The cells were grown to 70% con¯uence, trypsinized, and suspended in serum free medium at 10 7 cells/ml. Four hundred ml of this suspension were mixed with 40 mg DNA in an electroporation cuvette. Vimentin and tsp53 expression vectors were linearized and cotransfected with the pM5neo (Laker et al., 1987) and the pHygvector (Sugden et al., 1985) respectively. The cells were exposed to one electric pulse of 260 V and 1500 mF in an Easyject plus genepulser (EuroGentec; Seraig, Belgium). After electroporation the cells were immediately diluted in prewarmed medium. Viable cells were seeded in culture dishes (1 10 cm) at 10 3 , 10 4 and 10 5 per plate. The viability of the cells was determined by staining with trypan blue. The selection procedure was started 48 h after electroporation by adding Geneticin (400 mg/ml) or Hygromycin B (100 mg/ml). Subclones isolated were tested for the expression of vimentin and tsp53 by indirect immunouorescence.
Transient transfection
Cells grown to 50% con¯uence on glass coverslips were transiently transfected with the expression vector D61 coding for an aminoterminal mutated vimentin protein.
Two mg of plasmid DNA were diluted in 100 ml DMEM without FCS and incubated with 10 ml Superfect (Qiagen, Germany). Cells grown on cover slips were incubated for 2 h with the DNA-Superfect complexes in 700 ml DMEM. The transfection medium was removed and the cells were allowed to express the aminoterminal mutated vimentin for 24 h. Vimentin and p53 were localized in the ®xed cells by indirect immuno¯uorescence.
Preparation of cytoskeletons
The cells were grown on glass coverslips to 50% con¯uence. The coverslips were rinsed brie¯y with PBS and lysed with Triton X-100 in a PIPES buered salt solution (80 mM PIPES pH 6.8; 4% PEG 6000; 1 mM MgCl 2 ; 0.5% Triton X-100; 4 mM EGTA; 1% aprotinin (Trasylol: Bayer; Leverkusen, Germany); 50 mM Leupeptin) (Okabe and Hirokawa, 1988) . The cytoskeletons were washed with 25 mM HEPES pH 7.4; 29 mM NaCl; 100 mM KCl; 0.96 mM NaH 2 PO 4 ; 5 mM MgCl 2 for 5 min and ®xed for 20 min with 2% paraformaldehyde. All steps were carried out at 378C in a volume of 100 ml.
Drug treatment of cells and immuno¯uorescence
Cells were grown on glass coverslips to 50% con¯uence, incubated with cytochalasin B (10 mg/ml) (Sigma, Munich, Germany) for 15 min, or with vinblastin (Sigma) for 2 h, or were left untreated. They were then rinsed with PBS, extracted, and ®xed with 1% paraformaldehyde for 15 min. Alternatively they were immediately ®xed with acetone (7208C) for 20 min. The ®xed cells were washed with PBS for 10 min. To minimize unspeci®c binding the samples were saturated with 1% normal goat serum prior to antibody incubation. The following probes were used for localizing cytoskeletal proteins and p53: a rabbit anti-p53 antiserum, produced in our laboratory against puri®ed, SDS denatured mouse wt p53 protein, the mouse monoclonal anti-p53 antibody pAb 248, the mouse monoclonal anti-vimentin antibodies V9 and VIM3B4 (Boehringer Mannheim, Mannheim, Germany), a monoclonal antibody to b-tubulin (Boehringer Mannheim), and FITC-conjugated phalloidin (Sigma). Goat anti-mouse IgG and goat anti-rabbit IgG (Dianova, Hamburg, Germany) conjugated with FITC or Texas-Red were used as second antibodies. Incubation with antibodies was done for 30 min each, followed by washing with PBS for 20 min. Photographs were taken in a Leica CLSM.
Immunoelectron microscopy of cytoskeletons
Cells grown on glass coverslips were lysed with a nonionic detergent as described above and ®xed with 1% paraformaldehyde for 20 min at room temperature.
Cytoskeletons were blocked with normal goat serum for 20 min and labeled with antibodies to vimentin (V9) or p53 (either mouse monoclonal antibody 248 or rabbit antiserum) for 20 min at room temperature. Goat anti-mouse IgG conjugated with 10 nm gold particles (Biocell, UK) and goat anti-rabbit IgG conjugated with 5 nm gold particles (Biocell, UK) were used as secondary antibodies. The cells were post®xed with 0.5% glutaraldehyde in PBS for 1 h, dehydrated through a graded series of ethanol and critical point dried with CO 2 . The dried cytoskeletons were shadowed with pure carbon at a 908 angle at 10 77 mbar in a Biotech 2000 (Leybold-Haereus, Germany). They werē oated on 35% hydro¯uoric acid, washed on distilled water and mounted on copper grids without a supporting ®lm. Micrographs were taken in a Philips CM 120 transmission microscope.
Fractionation of cells
Subcon¯uent cells were washed twice with PBS and lysed in 2 ml lysis buer I (10 mM HEPES pH 6.6; 10% Glycerol; 5 mM MgCl 2 ; 1% NP40; 1 mM EGTA; 1% aprotinin, 50 mM Leupeptin). The soluble fraction was removed and the insoluble material was sonicated in 2 ml lysis buer. The proteins were precipitated with 10% TCA, washed with acetone and dissolved in sample-buer (Laemmli, 1970) . They were separated on a 10% polyacrylamide gel, transferred to nitrocellulose and detected by Western immunoblotting.
Western immunoblotting
About 2610 6 cells of a subcon¯uent culture were lysed with 1 ml sample buer. 20 ml of each probe were run on a 10% polyacrylamide gel and blotted onto nitrocellulose as previously described (Staufenbiel and Deppert, 1983) . The nitrocellulose sheets were blocked with 2% BSA in Trisbuered salt solution (20 mM Tris/HCl pH 7.6; 150 mM NaCl) containing 0.05% Tween. For detection of vimentin the sheets were incubated with either the mouse antivimentin antibodies V9 or VIM3B4, and subsequently with peroxidase conjugated donkey anti-mouse IgG (Biorad, Munich, Germany). For detection of p53 the sheets were incubated with the monoclonal antibody pAb421, secondly with a rabbit anti-mouse IgG (DAKO, Hamburg, Germany), and then with a peroxidase conjugated mouse antibody (DAKO, Hamburg, Germany). Bound peroxidase was detected using the ECL Western-blot detection kit (Amersham; Braunschweig, Germany) and chemiluminescence was visualized by exposing the membrane to X-ray ®lms.
